Skip to content
Parakho

Fischer Medical Ventures Ltd

NSE FISCHERBSE 524743

Q4 FY26

Revenue
₹97.73 Cr
Profit after tax
₹-7.12 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ4 FY26vs a year agoFY26
Revenue from operations97.73—308.58
Other income1.28—12.31
Total income99.01—320.89
Employee benefit expense4.02—15.09
Finance costs3.61—5.83
Depreciation & amortisation0.93—2.98
Total expenses101.26—274.30
Profit before tax-2.25—46.58
Tax expense4.86—15.34
Profit after tax-7.12—31.02
Total comprehensive income-7.12—30.97
Earnings per share
Earnings per share, basic₹-0.11₹0.48
Earnings per share, diluted₹0.10₹0.45

Q4 FY26 and FY26 — from the company’s filing with NSE. Source

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Fischer Medical Ventures Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 32 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 24 Aug 2026.